Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function

Metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyeridemia, hyper‐low‐density lipoproteins, hypo‐high‐density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that—in combination with genetic susceptibility and abdominal obesity—are ri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular biochemistry 2007-04, Vol.100 (6), p.1352-1369
1. Verfasser: Nicolson, Garth L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1369
container_issue 6
container_start_page 1352
container_title Journal of cellular biochemistry
container_volume 100
creator Nicolson, Garth L.
description Metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyeridemia, hyper‐low‐density lipoproteins, hypo‐high‐density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that—in combination with genetic susceptibility and abdominal obesity—are risk factors for type 2 diabetes, vascular inflammation, atherosclerosis, and renal, liver and heart disease. One of the defects in metabolic syndrome and its associated diseases is excess cellular oxidative stress (mediated by reactive oxygen and nitrogen species, ROS/RNS) and oxidative damage to mitochondrial components, resulting in reduced efficiency of the electron transport chain. Recent evidence indicates that reduced mitochondrial function caused by ROS/RNS membrane oxidation is related to fatigue, a common complaint of MS patients. Lipid replacement therapy (LRT) administered as a nutritional supplement with antioxidants can prevent excess oxidative membrane damage, restore mitochondrial and other cellular membrane functions and reduce fatigue. Recent clinical trials have shown the benefit of LRT plus antioxidants in restoring mitochondrial electron transport function and reducing moderate to severe chronic fatigue. Thus LRT plus antioxidant supplements should be considered for metabolic syndrome patients who suffer to various degrees from fatigue. J. Cell. Biochem. 100: 1352–1369, 2007. © 2007 Wiley‐Liss, Inc.
doi_str_mv 10.1002/jcb.21247
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70305040</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70305040</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4277-7ba524e36196677e7f9a46273862e16a4f9675bb13a0b32db55d2a67719e50a73</originalsourceid><addsrcrecordid>eNp1kc1u1DAURi1ERYfCghdAXiGxSOu_2IQdjKBQtcCi0KVlOzfCxYlTO4HO-_RB8WSmsOrqStfnO77Sh9ALSo4pIezk2tljRplQj9CKkkZVQgrxGK2I4qRinLJD9DTna0JI03D2BB1SxQSnVK3Q3QVMxsbgHc6boU2xB2yGFvd-iu5nLBtvAu7mwU0-Dm_xRQzg5mASTjAG46CHYVoSZijErW_LxHkex7A8ZTxFPCb4vcV66G0yA-AR0oJunUs4QZ5igge-fYYOOhMyPN_PI_T944fL9afq_Ovp5_W788oJplSlrKmZAC5pI6VSoLrGCMkUfyMZUGlE10hVW0u5IZaz1tZ1y0whaQM1MYofoVc775jizVxO0r3PDkIoN8c5a0U4qYkgBXy9A12KOSfo9Jh8b9JGU6K3lehSiV4qKezLvXS2PbT_yX0HBTjZAX98gM3DJn22fn-vrHYJnye4_Zcw6ZeWiqtaX3051euG_bj6dsk05X8BqImo-Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70305040</pqid></control><display><type>article</type><title>Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Nicolson, Garth L.</creator><creatorcontrib>Nicolson, Garth L.</creatorcontrib><description>Metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyeridemia, hyper‐low‐density lipoproteins, hypo‐high‐density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that—in combination with genetic susceptibility and abdominal obesity—are risk factors for type 2 diabetes, vascular inflammation, atherosclerosis, and renal, liver and heart disease. One of the defects in metabolic syndrome and its associated diseases is excess cellular oxidative stress (mediated by reactive oxygen and nitrogen species, ROS/RNS) and oxidative damage to mitochondrial components, resulting in reduced efficiency of the electron transport chain. Recent evidence indicates that reduced mitochondrial function caused by ROS/RNS membrane oxidation is related to fatigue, a common complaint of MS patients. Lipid replacement therapy (LRT) administered as a nutritional supplement with antioxidants can prevent excess oxidative membrane damage, restore mitochondrial and other cellular membrane functions and reduce fatigue. Recent clinical trials have shown the benefit of LRT plus antioxidants in restoring mitochondrial electron transport function and reducing moderate to severe chronic fatigue. Thus LRT plus antioxidant supplements should be considered for metabolic syndrome patients who suffer to various degrees from fatigue. J. Cell. Biochem. 100: 1352–1369, 2007. © 2007 Wiley‐Liss, Inc.</description><identifier>ISSN: 0730-2312</identifier><identifier>EISSN: 1097-4644</identifier><identifier>DOI: 10.1002/jcb.21247</identifier><identifier>PMID: 17243117</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Animals ; antioxidants ; Antioxidants - administration &amp; dosage ; Antioxidants - pharmacology ; Antioxidants - therapeutic use ; atherosclerosis ; Cell Membrane - drug effects ; Cell Membrane - metabolism ; diabetes ; dietary supplement ; fatigue ; heart disease ; Humans ; lipids ; liver disease ; Metabolic Syndrome - metabolism ; Metabolic Syndrome - physiopathology ; Metabolic Syndrome - prevention &amp; control ; mitochondria ; Mitochondria - drug effects ; Mitochondria - physiology ; Models, Biological ; Oxidation-Reduction - drug effects ; Oxidative Stress - drug effects ; renal disease ; vascular inflammation</subject><ispartof>Journal of cellular biochemistry, 2007-04, Vol.100 (6), p.1352-1369</ispartof><rights>Copyright © 2007 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4277-7ba524e36196677e7f9a46273862e16a4f9675bb13a0b32db55d2a67719e50a73</citedby><cites>FETCH-LOGICAL-c4277-7ba524e36196677e7f9a46273862e16a4f9675bb13a0b32db55d2a67719e50a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcb.21247$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcb.21247$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17243117$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nicolson, Garth L.</creatorcontrib><title>Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function</title><title>Journal of cellular biochemistry</title><addtitle>J. Cell. Biochem</addtitle><description>Metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyeridemia, hyper‐low‐density lipoproteins, hypo‐high‐density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that—in combination with genetic susceptibility and abdominal obesity—are risk factors for type 2 diabetes, vascular inflammation, atherosclerosis, and renal, liver and heart disease. One of the defects in metabolic syndrome and its associated diseases is excess cellular oxidative stress (mediated by reactive oxygen and nitrogen species, ROS/RNS) and oxidative damage to mitochondrial components, resulting in reduced efficiency of the electron transport chain. Recent evidence indicates that reduced mitochondrial function caused by ROS/RNS membrane oxidation is related to fatigue, a common complaint of MS patients. Lipid replacement therapy (LRT) administered as a nutritional supplement with antioxidants can prevent excess oxidative membrane damage, restore mitochondrial and other cellular membrane functions and reduce fatigue. Recent clinical trials have shown the benefit of LRT plus antioxidants in restoring mitochondrial electron transport function and reducing moderate to severe chronic fatigue. Thus LRT plus antioxidant supplements should be considered for metabolic syndrome patients who suffer to various degrees from fatigue. J. Cell. Biochem. 100: 1352–1369, 2007. © 2007 Wiley‐Liss, Inc.</description><subject>Animals</subject><subject>antioxidants</subject><subject>Antioxidants - administration &amp; dosage</subject><subject>Antioxidants - pharmacology</subject><subject>Antioxidants - therapeutic use</subject><subject>atherosclerosis</subject><subject>Cell Membrane - drug effects</subject><subject>Cell Membrane - metabolism</subject><subject>diabetes</subject><subject>dietary supplement</subject><subject>fatigue</subject><subject>heart disease</subject><subject>Humans</subject><subject>lipids</subject><subject>liver disease</subject><subject>Metabolic Syndrome - metabolism</subject><subject>Metabolic Syndrome - physiopathology</subject><subject>Metabolic Syndrome - prevention &amp; control</subject><subject>mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - physiology</subject><subject>Models, Biological</subject><subject>Oxidation-Reduction - drug effects</subject><subject>Oxidative Stress - drug effects</subject><subject>renal disease</subject><subject>vascular inflammation</subject><issn>0730-2312</issn><issn>1097-4644</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAURi1ERYfCghdAXiGxSOu_2IQdjKBQtcCi0KVlOzfCxYlTO4HO-_RB8WSmsOrqStfnO77Sh9ALSo4pIezk2tljRplQj9CKkkZVQgrxGK2I4qRinLJD9DTna0JI03D2BB1SxQSnVK3Q3QVMxsbgHc6boU2xB2yGFvd-iu5nLBtvAu7mwU0-Dm_xRQzg5mASTjAG46CHYVoSZijErW_LxHkex7A8ZTxFPCb4vcV66G0yA-AR0oJunUs4QZ5igge-fYYOOhMyPN_PI_T944fL9afq_Ovp5_W788oJplSlrKmZAC5pI6VSoLrGCMkUfyMZUGlE10hVW0u5IZaz1tZ1y0whaQM1MYofoVc775jizVxO0r3PDkIoN8c5a0U4qYkgBXy9A12KOSfo9Jh8b9JGU6K3lehSiV4qKezLvXS2PbT_yX0HBTjZAX98gM3DJn22fn-vrHYJnye4_Zcw6ZeWiqtaX3051euG_bj6dsk05X8BqImo-Q</recordid><startdate>20070415</startdate><enddate>20070415</enddate><creator>Nicolson, Garth L.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070415</creationdate><title>Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function</title><author>Nicolson, Garth L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4277-7ba524e36196677e7f9a46273862e16a4f9675bb13a0b32db55d2a67719e50a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>antioxidants</topic><topic>Antioxidants - administration &amp; dosage</topic><topic>Antioxidants - pharmacology</topic><topic>Antioxidants - therapeutic use</topic><topic>atherosclerosis</topic><topic>Cell Membrane - drug effects</topic><topic>Cell Membrane - metabolism</topic><topic>diabetes</topic><topic>dietary supplement</topic><topic>fatigue</topic><topic>heart disease</topic><topic>Humans</topic><topic>lipids</topic><topic>liver disease</topic><topic>Metabolic Syndrome - metabolism</topic><topic>Metabolic Syndrome - physiopathology</topic><topic>Metabolic Syndrome - prevention &amp; control</topic><topic>mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - physiology</topic><topic>Models, Biological</topic><topic>Oxidation-Reduction - drug effects</topic><topic>Oxidative Stress - drug effects</topic><topic>renal disease</topic><topic>vascular inflammation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nicolson, Garth L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nicolson, Garth L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function</atitle><jtitle>Journal of cellular biochemistry</jtitle><addtitle>J. Cell. Biochem</addtitle><date>2007-04-15</date><risdate>2007</risdate><volume>100</volume><issue>6</issue><spage>1352</spage><epage>1369</epage><pages>1352-1369</pages><issn>0730-2312</issn><eissn>1097-4644</eissn><abstract>Metabolic syndrome consists of a cluster of metabolic conditions, such as hypertriglyeridemia, hyper‐low‐density lipoproteins, hypo‐high‐density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that—in combination with genetic susceptibility and abdominal obesity—are risk factors for type 2 diabetes, vascular inflammation, atherosclerosis, and renal, liver and heart disease. One of the defects in metabolic syndrome and its associated diseases is excess cellular oxidative stress (mediated by reactive oxygen and nitrogen species, ROS/RNS) and oxidative damage to mitochondrial components, resulting in reduced efficiency of the electron transport chain. Recent evidence indicates that reduced mitochondrial function caused by ROS/RNS membrane oxidation is related to fatigue, a common complaint of MS patients. Lipid replacement therapy (LRT) administered as a nutritional supplement with antioxidants can prevent excess oxidative membrane damage, restore mitochondrial and other cellular membrane functions and reduce fatigue. Recent clinical trials have shown the benefit of LRT plus antioxidants in restoring mitochondrial electron transport function and reducing moderate to severe chronic fatigue. Thus LRT plus antioxidant supplements should be considered for metabolic syndrome patients who suffer to various degrees from fatigue. J. Cell. Biochem. 100: 1352–1369, 2007. © 2007 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>17243117</pmid><doi>10.1002/jcb.21247</doi><tpages>18</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0730-2312
ispartof Journal of cellular biochemistry, 2007-04, Vol.100 (6), p.1352-1369
issn 0730-2312
1097-4644
language eng
recordid cdi_proquest_miscellaneous_70305040
source MEDLINE; Wiley Online Library All Journals
subjects Animals
antioxidants
Antioxidants - administration & dosage
Antioxidants - pharmacology
Antioxidants - therapeutic use
atherosclerosis
Cell Membrane - drug effects
Cell Membrane - metabolism
diabetes
dietary supplement
fatigue
heart disease
Humans
lipids
liver disease
Metabolic Syndrome - metabolism
Metabolic Syndrome - physiopathology
Metabolic Syndrome - prevention & control
mitochondria
Mitochondria - drug effects
Mitochondria - physiology
Models, Biological
Oxidation-Reduction - drug effects
Oxidative Stress - drug effects
renal disease
vascular inflammation
title Metabolic syndrome and mitochondrial function: Molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A53%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20syndrome%20and%20mitochondrial%20function:%20Molecular%20replacement%20and%20antioxidant%20supplements%20to%20prevent%20membrane%20peroxidation%20and%20restore%20mitochondrial%20function&rft.jtitle=Journal%20of%20cellular%20biochemistry&rft.au=Nicolson,%20Garth%20L.&rft.date=2007-04-15&rft.volume=100&rft.issue=6&rft.spage=1352&rft.epage=1369&rft.pages=1352-1369&rft.issn=0730-2312&rft.eissn=1097-4644&rft_id=info:doi/10.1002/jcb.21247&rft_dat=%3Cproquest_cross%3E70305040%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70305040&rft_id=info:pmid/17243117&rfr_iscdi=true